Kenneth Reay Code - Dec 31, 2024 Form 4 Insider Report for BIOLARGO, INC. (BLGO)

Role
Chief Science Officer, Director
Signature
/s/ John R. Browning, attorney-in-fact
Stock symbol
BLGO
Transactions as of
Dec 31, 2024
Transactions value $
$10,957
Form type
4
Date filed
1/3/2025, 06:40 PM
Previous filing
Jan 3, 2024
Next filing
Jul 16, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLGO Common stock Award $11K +57.7K +0.23% $0.19 25.1M Dec 31, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares received from Issuer in exchange for a reduction in amounts owed by Issuer to Reporting Person for salary and unreimbursed business expenses (equal to the product of the number of shares and acquisition price per share).
F2 Aggregate total shares includes 22,139,012 shares owned indirectly by Reporting Person through a wholly owned corporation.